In collaboration with Merck, a global biopharmaceutical company, we want to spread the word about the importance of clinical trials. In the video above, Dr. Adrelia Allen, Executive Director of ...

Merck Chairman and CEO Robert Davis joins 'Mad Money' host Jim Cramer to talk quarterly results, what sectors it is seeing strength in, its recent acquisition of Verona Pharma and more. Got a ...

Merck expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The company's first-quarter results beat estimates, with sales of $15.5 ...

Gina Sanchez, chief market strategist at Lido Advisors, joins CNBC's 'The Exchange' to discuss four stocks: Merck, Abbott, Cigna, and Zoom. Got a confidential news tip? We want to hear from you. Sign ...

Merck officially asked the FDA to authorize its antiviral pill to treat Covid-19. The company says the pill cuts hospitalizations and deaths in half for unvaccinated ...

Merck & Co. agreed to acquire Cidara Therapeutics Inc., a biotech company developing a flu treatment, as part of its ongoing efforts to make up for the upcoming patent loss of its blockbuster cancer ...